Pompe R - Search Results

1

Impact of Age on Perioperative Outcomes at Radical Prostatectomy: A Population-Based Study.

Preisser F, Mazzone E, Nazzani S, Knipper S, Tian Z, Mandel P, Pompe R, Saad F, Montorsi F, Shariat SF, Huland H, Graefen M, Tilki D, Karakiewicz PI. Preisser F, et al. Among authors: pompe r. Eur Urol Focus. 2020 Nov 15;6(6):1213-1219. doi: 10.1016/j.euf.2018.12.006. Epub 2018 Dec 26. Eur Urol Focus. 2020. PMID: 30594487

2

North American Population-Based Validation of the National Comprehensive Cancer Network Practice Guideline Recommendation of Pelvic Lymphadenectomy in Contemporary Prostate Cancer.

Leyh-Bannurah SR, Budäus L, Pompe R, Zaffuto E, Briganti A, Abdollah F, Montorsi F, Schiffmann J, Menon M, Shariat SF, Fisch M, Chun F, Huland H, Graefen M, Karakiewicz PI. Leyh-Bannurah SR, et al. Among authors: pompe r. Prostate. 2017 Apr;77(5):542-548. doi: 10.1002/pros.23292. Epub 2017 Jan 17. Prostate. 2017. PMID: 28093788

3

Incidence, Risk Factors, Management, and Complications of Rectal Injuries During Radical Prostatectomy.

Mandel P, Linnemannstöns A, Chun F, Schlomm T, Pompe R, Budäus L, Rosenbaum C, Ludwig T, Dahlem R, Fisch M, Graefen M, Huland H, Tilki D, Steuber T. Mandel P, et al. Among authors: pompe r. Eur Urol Focus. 2018 Jul;4(4):554-557. doi: 10.1016/j.euf.2017.01.008. Epub 2017 Feb 7. Eur Urol Focus. 2018. PMID: 28753847

4

Hospitalization before surgery and subsequent risk of infective complications after radical cystectomy: A population-based analysis.

Zaffuto E, Pompe R, Bondarenko HD, Moschini M, Dell'Oglio P, Gandaglia G, Fossati N, Shariat SF, Montorsi F, Briganti A, Karakiewicz PI. Zaffuto E, et al. Among authors: pompe r. Urol Oncol. 2017 Nov;35(11):659.e7-659.e12. doi: 10.1016/j.urolonc.2017.07.004. Epub 2017 Jul 26. Urol Oncol. 2017. PMID: 28755960

5

Obesity paradox in prostate cancer: increased body mass index was associated with decreased risk of metastases after surgery in 13,667 patients.

Schiffmann J, Karakiewicz PI, Rink M, Manka L, Salomon G, Tilki D, Budäus L, Pompe R, Leyh-Bannurah SR, Haese A, Hammerer P, Huland H, Graefen M, Tennstedt P. Schiffmann J, et al. Among authors: pompe r. World J Urol. 2018 Jul;36(7):1067-1072. doi: 10.1007/s00345-018-2240-8. Epub 2018 Mar 2. World J Urol. 2018. PMID: 29497861

6

Oncological, functional and perioperative outcomes in transplant patients after radical prostatectomy.

Beyer B, Mandel P, Michl U, Pompe RS, Veleva V, Steuber T, Huland H, Graefen M, Tilki D. Beyer B, et al. World J Urol. 2016 Aug;34(8):1101-5. doi: 10.1007/s00345-015-1758-2. Epub 2016 Jan 12. World J Urol. 2016. PMID: 26757719

7

Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy.

Adam M, Tennstedt P, Lanwehr D, Tilki D, Steuber T, Beyer B, Thederan I, Heinzer H, Haese A, Salomon G, Budäus L, Michl U, Pehrke D, Stattin P, Bernard J, Klaus B, Pompe RS, Petersen C, Huland H, Graefen M, Schwarz R, Huber W, Loeb S, Schlomm T. Adam M, et al. Among authors: pompe rs. Eur Urol. 2017 Mar;71(3):330-336. doi: 10.1016/j.eururo.2016.11.015. Epub 2016 Nov 22. Eur Urol. 2017. PMID: 27887941

8

Population-Based Validation of the 2014 ISUP Gleason Grade Groups in Patients Treated With Radical Prostatectomy, Brachytherapy, External Beam Radiation, or no Local Treatment.

Pompe RS, Davis-Bondarenko H, Zaffuto E, Tian Z, Shariat SF, Leyh-Bannurah SR, Schiffmann J, Saad F, Huland H, Graefen M, Tilki D, Karakiewicz PI. Pompe RS, et al. Prostate. 2017 May;77(6):686-693. doi: 10.1002/pros.23316. Epub 2017 Feb 3. Prostate. 2017. PMID: 28156003

9

Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression.

Schiffmann J, Salomon G, Tilki D, Budäus L, Karakiewicz PI, Leyh-Bannurah SR, Pompe RS, Haese A, Heinzer H, Huland H, Graefen M, Tennstedt P. Schiffmann J, et al. Urol Oncol. 2017 May;35(5):243-249. doi: 10.1016/j.urolonc.2016.12.014. Epub 2017 Feb 1. Urol Oncol. 2017. PMID: 28161322

10

Oncologic and Functional Outcomes after Radical Prostatectomy for High or Very High Risk Prostate Cancer: European Validation of the Current NCCN® Guideline.

Pompe RS, Karakiewicz PI, Tian Z, Mandel P, Steuber T, Schlomm T, Salomon G, Graefen M, Huland H, Tilki D. Pompe RS, et al. J Urol. 2017 Aug;198(2):354-361. doi: 10.1016/j.juro.2017.02.070. Epub 2017 Feb 16. J Urol. 2017. PMID: 28216329

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters